Am J Perinatol 2017; 34(14): 1411-1416
DOI: 10.1055/s-0037-1603940
Original Article
Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.

Prospective Comparison of Enfamil and Similac Liquid Human Milk Fortifier on Clinical Outcomes in Premature Infants

Navin Kumar
1   Division of Neonatology, Hurley Medical Center, Flint, Michigan
,
Ranjan Monga
1   Division of Neonatology, Hurley Medical Center, Flint, Michigan
,
Venkatesh Sampath
2   Division of Neonatology, Children's Mercy Hospital, Kansas City, Missouri
,
Barb Ehrhart
1   Division of Neonatology, Hurley Medical Center, Flint, Michigan
› Author Affiliations
Further Information

Publication History

16 March 2017

18 May 2017

Publication Date:
21 June 2017 (online)

Abstract

Objective To compare growth and metabolic outcomes of premature infants receiving either Enfamil liquid human milk fortifier (ELHMF) or Similac liquid human milk fortifier (SLHMF).

Study Design Infants born at ≤31 weeks' gestational age (GA) with birth weights <1,500 g and exclusively fed on human milk (mother's milk and/or donor milk) were prospectively assigned alternatively to one of the two liquid human milk fortifier (LHMF) groups. Baseline demographic, growth, enteral nutrition, and laboratory data were compared after fortification.

Results In total, 31 preterm infants were recruited (ELHMF = 16; SLHMF = 15) with a mean GA of 27.1 ± 2.1 weeks and birth weight of 993 ± 245 g. The SLHMF group had significantly better weight gain as measured by individual weight z-scores (p = 0.008), better median weight gain velocity (p = 0.014), and less metabolic acidosis (p = 0.016). Overall weight gain was significantly better on mother's own milk in both the fortifier groups. The SLHMF group showed a trend toward higher growth velocity on donor milk compared with ELHMF (p = 0.06). We also observed a higher reticulocyte count (p = 0.003) in the SLHMF group compared with the ELHMF group.

Conclusion In premature infants, between the two liquid human milk fortifiers, ELHMF fortifier is associated with relatively less weight gain and more metabolic acidosis.

 
  • References

  • 1 American Academy of Pediatrics. Pediatric Nutrition Handbook. 6th ed. Washington, DC: American Academy of Pediatrics; 2009
  • 2 Groh-Wargo S, Thompson M, Cox JH. Nutritional Care for High-Risk Newborns. Chicago, IL: Precept Press; 1994
  • 3 Sullivan S, Schanler RJ, Kim JH. , et al. An exclusively human milk-based diet is associated with a lower rate of necrotizing enterocolitis than a diet of human milk and bovine milk-based products. J Pediatr 2010; 156 (04) 562-567.e1
  • 4 Tsang RC, Uauy R, Koletzko B, Zlotkin SH. , eds. Nutrition of the Preterm Infant: Scientific Basis and Practical Guidelines. Cincinnati, OH: Digital Educational Publishing Inc.; 2005: 415-418
  • 5 Clark RH, Thomas P, Peabody J. Extrauterine growth restriction remains a serious problem in prematurely born neonates. Pediatrics 2003; 111 (5 Pt 1): 986-990
  • 6 Section on Breastfeeding. Breastfeeding and the use of human milk. Pediatrics 2012; 129 (03) e827-e841
  • 7 Hawthorne KM, Abrams SA. Safety and efficacy of human milk fortification for very-low-birthweight infants. Nutr Rev 2004; 62 (12) 482-485
  • 8 Valentine CJ, Fernandez S, Rogers LK. , et al. Early amino-acid administration improves preterm infant weight. J Perinatol 2009; 29 (06) 428-432
  • 9 Stephens BE, Walden RV, Gargus RA. , et al. First-week protein and energy intakes are associated with 18-month developmental outcomes in extremely low birth weight infants. Pediatrics 2009; 123 (05) 1337-1343
  • 10 Maggio L, Costa S, Gallini F. Human milk fortifiers in very low birth weight infants. Early Hum Dev 2009; 85 (10, Suppl): S59-S61
  • 11 Kuschel CA, Harding JE. Multicomponent fortified human milk for promoting growth in preterm infants. Cochrane Database Syst Rev 2004; ; ( (01) CD000343 . Doi: 10.1002/14651858.CD000343.pub2
  • 12 Centers for Disease Control and Prevention (CDC). Enterobacter sakazakii infections associated with the use of powdered infant formula--Tennessee, 2001. Morb Mortal Wkly Rep 2002; 51 (14) 297-300
  • 13 Hanson C, Sundermeier J, Dugick L, Lyden E, Anderson-Berry AL. Implementation, process, and outcomes of nutrition best practices for infants <1500 g. Nutr Clin Pract 2011; 26 (05) 614-624
  • 14 Ehrenkranz RA, Dusick AM, Vohr BR, Wright LL, Wrage LA, Poole WK. Growth in the neonatal intensive care unit influences neurodevelopmental and growth outcomes of extremely low birth weight infants. Pediatrics 2006; 117 (04) 1253-1261
  • 15 Thoene M, Hanson C, Lyden E, Dugick L, Ruybal L, Anderson-Berry A. Comparison of the effect of two human milk fortifiers on clinical outcomes in premature infants. Nutrients 2014; 6 (01) 261-275
  • 16 Cibulskis CC, Armbrecht ES. Association of metabolic acidosis with bovine milk-based human milk fortifiers. J Perinatol 2015; 35 (02) 115-119
  • 17 Thoene M, Lyden E, Weishaar K. , et al. Comparison of a powdered, acidified liquid, and non-acidified liquid human milk fortifier on clinical outcomes in premature infants. Nutrients 2016; 8 (08) E451 . Doi: 10.3390/nu8080451
  • 18 Abbott Laboratories. Abbott nutrition (internet). 2015 . Available at: http://Abbottnutrition.com/brands/products/similac-human-milk-fortifier-hydrolyzed-protein-concentrated-liquid
  • 19 Mead Johnson & Company, LLC. Enfamil human milk fortifier acidified liquid (internet). 2016 . Available at: http://www.meadjohnson.com/pediatrics/us-en/product-information/products/premature/enfamil-human-milk-fortifier-acidified-liquid#product-features
  • 20 Donovan R, Kelly SG, Prazad P. , et al. The effects of human milk fortification on nutrients and milk properties. J Perinatol 2017; 37 (01) 42-48
  • 21 Fenton TR, Sauve RS. Using the LMS method to calculate z-scores for the Fenton preterm infant growth chart. Eur J Clin Nutr 2007; 61 (12) 1380-1385
  • 22 Fenton TR. A new growth chart for preterm babies: Babson and Benda's chart updated with recent data and a new format. BMC Pediatr 2003; 3: 13 . Doi: 10.1186/1471-2431-3-13
  • 23 Patel AL, Engstrom JL, Meier PP, Kimura RE. Accuracy of methods for calculating postnatal growth velocity for extremely low birth weight infants. Pediatrics 2005; 116 (06) 1466-1473
  • 24 Khaldi N, Shields DC. Shift in the isoelectric-point of milk proteins as a consequence of adaptive divergence between the milks of mammalian species. Biol Direct 2011; 6: 40 . Doi: 10.1186/1745-6150-6-40
  • 25 Moya F, Sisk PM, Walsh KR, Berseth CL. A new liquid human milk fortifier and linear growth in preterm infants. Pediatrics 2012; 130 (04) e928-e935
  • 26 Manz F, Kalhoff H, Remer T. Renal acid excretion in early infancy. Pediatr Nephrol 1997; 11 (02) 231-243
  • 27 Rochow N, Jochum F, Redlich A. , et al. Fortification of breast milk in VLBW infants: metabolic acidosis is linked to the composition of fortifiers and alters weight gain and bone mineralization. Clin Nutr 2011; 30 (01) 99-105
  • 28 Kalhoff H, Diekmann L, Rudloff S, Manz F. Renal excretion of calcium and phosphorus in premature infants with incipient late metabolic acidosis. J Pediatr Gastroenterol Nutr 2001; 33 (05) 565-569
  • 29 Eckardt KU, Kurtz A, Bauer C. Triggering of erythropoietin production by hypoxia is inhibited by respiratory and metabolic acidosis. Am J Physiol 1990; 258 (3 Pt 2): R678-R683